Worse survival for TP53 (p53)-mutated breast cancer patients receiving adjuvant CMF, Ann. Oncol, vol.16, pp.743-748, 2005. ,
Effect of high dimension: By an example of a two sample problem, FGFR3 and TP53 gene mutations define two distinct pathways in urothelial cell carcinoma of the bladder, pp.311-329, 1996. ,
Cyclin D1 in mammary carcinoma, The Journal of Pathology, vol.9, issue.3, pp.267-269, 1997. ,
DOI : 10.1002/(SICI)1096-9896(199703)181:3<267::AID-PATH783>3.0.CO;2-X
Controlling the false discovery rate: A practical and powerful approach to multiple testing A two-sample test for high-dimensional data with applications to gene-set testing. Ann. Statist Cell cycle genes and ovarian cancer susceptibility: A tagSNP analysis, J. Roy. Statist. Soc. Ser. B Br. J. Cancer, vol.57, issue.101, pp.289-300, 1995. ,
Power of the noncentral F test: Effect of additional variates on Hotelling's T 2 -test, J. Amer. Statist. Assoc, vol.69, pp.174-180, 1974. ,
Multiple Testing Procedures with Applications to Genomics Dietary restriction reduces insulin-like growth factor I levels, which modulates apoptosis, cell proliferation, and tumor progression in p53-deficient mice, Cancer Res, vol.57, pp.4667-4672, 1997. ,
Outcome signature genes in breast cancer: Is there a unique set, Bioinformatics, vol.21, pp.171-178, 2005. ,
Cellular signaling by fibroblast growth factor receptors, Cytokine Growth Factor Rev, vol.16, pp.139-149, 2005. ,
Partial Differential Equations Amer Test of significance when data are curves, p53 status influences response to tamoxifen but not to fulvestrant in breast cancer cell lines, pp.1007-1021, 1998. ,
Molecular changes in tamoxifenresistant breast cancer: Relationship between estrogen receptor, HER-2, and p38 mitogenactivated protein kinase, J. Clin. Oncol, vol.23, pp.2469-2476, 2005. ,
Wavelets on graphs via spectral graph theory, 2009. ,
URL : https://hal.archives-ouvertes.fr/inria-00541855
The influence of feature selection methods on accuracy, stability and interpretability of molecular signatures, 2011. ,
URL : https://hal.archives-ouvertes.fr/hal-00559580
Increasing stability and interpretability of gene expression signatures, 2010. ,
URL : https://hal.archives-ouvertes.fr/hal-00448395
FGFR3 and Tp53 mutations in T1G3 transitional bladder carcinomas: Independent distribution and lack of association with prognosis, Clin. Cancer Res, vol.11, pp.5444-5450, 2005. ,
Cooperative action of tamoxifen and c-Src inhibition in preventing the growth of estrogen receptor-positive human breast cancer cells, Mol. Cancer Ther, vol.5, pp.3023-3031, 2006. ,
Molecular profiling of bladder cancer: Involvement of the TGF-beta pathway in bladder cancer progression, Cancer Lett, vol.265, pp.27-38, 2008. ,
Discovering regulatory and signalling circuits in molecular interaction networks, pp.233-240, 2002. ,
Supplement A to More power via graphstructured tests for differential expression of gene networks, pp.10-1214, 2011. ,
Supplement B to " More power via graphstructured tests for differential expression of gene networks, pp.10-1214, 2011. ,
Supplement C to " More power via graphstructured tests for differential expression of gene networks, pp.10-1214, 2011. ,
Group lasso with overlap and graph lasso, ICML'09: Proceedings of the 26th Annual International Conference on Machine Learning, pp.433-440, 2009. ,
Structured variable selection with sparsityinducing norms, p.WILLOW?INRIA, 2009. ,
URL : https://hal.archives-ouvertes.fr/inria-00377732
Pre-clinical evaluation of cyclin-dependent kinase 2 and 1 inhibition in anti-estrogen-sensitive and resistant breast cancer cells, Br. J. Cancer, vol.102, pp.342-350, 2010. ,
An Automatic Method of Solving Discrete Programming Problems, Econometrica, vol.28, issue.3, pp.497-520, 1960. ,
DOI : 10.2307/1910129
Predicting prognosis using molecular profiling in estrogen receptor-positive breast cancer treated with tamoxifen, BMC Genomics, vol.9, p.239, 2008. ,
Replicated microarray data A more powerful two-sample test in high dimensions using random projection, Statist. Sinica, vol.12, pp.31-46, 2002. ,
Estrogen receptor regulates E2F1 expression to mediate tamoxifen resistance, Mol. Cancer Res, vol.8, pp.343-352, 2010. ,
Hotelling's T 2 multivariate profiling for detecting differential expression in microarrays, Bioinformatics, vol.21, pp.3105-3113, 2005. ,
Inhibiting mutations in the transforming growth factor beta type 2 receptor in recurrent human breast cancer, Cancer Res, vol.61, pp.482-485, 2001. ,
Ras/Raf-1/MAPK pathway mediates response to tamoxifen but not chemotherapy in breast cancer patients, Clin. Cancer Res, vol.15, pp.1487-1495, 2009. ,
Generation of a concise gene panel for outcome prediction in urinary bladder cancer, J. Clin. Oncol, vol.27, pp.3929-3937, 2009. ,
Gene expression network analysis and applications to immunology, Bioinformatics, vol.23, p.850, 2007. ,
Group Lasso with overlaps: The latent group Lasso approach, 2011. ,
URL : https://hal.archives-ouvertes.fr/inria-00628498
A multigene assay to predict recurrence of tamoxifentreated , node-negative breast cancer, N. Engl. J. Med, vol.351, pp.2817-2826, 2004. ,
Molecular portraits of human breast tumours, Nature, vol.406, pp.747-752, 2000. ,
Expression of mucins and MUC6) and their prognostic significance in human breast cancer, Mod. Pathol, vol.18, pp.5-1295, 2005. ,
Classification of microarray data using gene networks, BMC Bioinformatics, vol.8, p.35, 2007. ,
URL : https://hal.archives-ouvertes.fr/hal-00433577
Levels of IL-1 beta control stimulatory/inhibitory growth of cancer cells, Front. Biosci, vol.11, pp.889-898, 2006. ,
Defining molecular profiles of poor outcome in patients with invasive bladder cancer using oligonucleotide microarrays, J. Clin. Oncol, vol.24, pp.778-789, 2006. ,
Regularized learning with networks of features, Neural Information Processing Systems, 2009. ,
Two molecular pathways to transitional cell carcinoma of the bladder, Cancer Res, vol.54, pp.784-788, 1994. ,
Transcriptional regulation of MUC2 by estrogen, Gastrointestinal Cancers Symposium, 2007. ,
A test for the mean vector with fewer observations than the dimension under nonnormality A test for the mean vector with fewer observations than the dimension. J. Multivariate Anal Matrix Perturbation Theory Regional copy number-independent deregulation of transcription in cancer, J. Multivariate Anal. Nat. Genet, vol.100, issue.38, pp.518-532, 1990. ,
Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles, Proc. Natl. Acad. Sci. USA, pp.15545-15550, 2005. ,
DOI : 10.1073/pnas.0506580102
On gene ranking using replicated microarray time course data FGFR1 amplification drives endocrine therapy resistance and is a therapeutic target in breast cancer, Biometrics Cancer Res, vol.65, issue.70, pp.40-51, 2009. ,
FGFR3 and P53 Characterize Alternative Genetic Pathways in the Pathogenesis of Urothelial Cell Carcinoma, Cancer Research, vol.64, issue.6, pp.1911-1914, 2004. ,
DOI : 10.1158/0008-5472.CAN-03-2421
Algorithms for detecting significantly mutated pathways in cancer, Lecture Notes in Computer Science, vol.6044, pp.506-521, 2010. ,
Inference of patient-specific pathway activities from multi-dimensional cancer genomics data using PARADIGM, ISMB, 2010. ,
Expression of MUC2 epithelial mucin in breast carcinoma, J. Clin. Pathol, vol.46, pp.922-925, 1993. ,
Glucocorticoid receptor-induced MAPK phosphatase-1 (MPK-1) expression inhibits paclitaxel-associated MAPK activation and contributes to breast cancer cell survival, J. Biol. Chem, vol.280, pp.4117-4124, 2005. ,